On the grounds of Art. 157 of POSA in connection with Art. 154 of the Public Offering of Securities Act and in connection with the expired deadline for acceptance of the tender offer submitted by Sopharma AD to the shareholders of Unipharm AD, we inform you about the results of the tender offering submitted by Sopharma AD for the purchase of the shares of the other shareholders of Unipharm AD.

Company, object of the offer: Unipharm AD, with management address Sofia 1797, Studentski grad, zh.k. Darvenitsa, Trayko Stanoev Str.

We are pleased to announce that the next step in the process of merging Achieve Life Sciences and Oncogenex has been completed with the approval of the merger by the US SEC. OncoGenex will hold a special shareholder meeting on 1 August 2017 to vote the merger. Shortly after the newly formed entity will trade on NASDAQ stock exchange under the ticker symbol ACHV.

Badania opublikowane przez Komisję Europejską w związku ze Światowym dniem bez dymu wskazują brak poniżenia ogólnej liczby palących osób w UE (26%) w porównaniu z 2014 r. Wśród ludzi w wieku 15 – 24 lata palenie tytoniu nawet wzrosło z 25% w 2014 do 29% w 2017 r.